Neurological assessment tool for screening infants during the first year after birth: The Brief-Hammersmith Infant Neurological Examination

Abstract

The article by Romeo et al. discusses a new tool called the Brief-Hammersmith Infant Neurological Examination (Brief-HINE). This tool is designed to help healthcare professionals assess the neurological health of infants during their first year after birth. Early identification of neurological issues (such as cerebral palsy [CP]) is crucial because timely intervention can lead to better outcomes for children.

The Brief-HINE is a simplified version of the original Hammersmith Infant Neurological Examination (see https://www.mackeith.co.uk/hammersmith-neurological-examinations/), which was more detailed and time-consuming. The authors aimed to create a shorter and easier assessment that could be used in various healthcare settings, making it more accessible for routine screenings.

Eleven items were selected from the original HINE, identifying those items previously found to better predict CP in both low- and high-risk infants. In the study, the researchers tested the Brief-HINE using data from a group of 228 infants with typical development at 2 years and in 82 infants who developed CP to evaluate its effectiveness. They looked at how well the tool could identify potential neurological problems by comparing the results to those from the original examination. The findings showed that the Brief-HINE is a reliable method for detecting neurological issues, providing a good balance between thoroughness and efficiency.

The Brief-HINE can help pediatricians, neurologists, and other healthcare providers screen infants quickly and effectively, ensuring that those who may need further evaluation or intervention receive appropriate care. The results of the study do not suggest that the Brief-HINE should completely replace the longer full HINE, but rather be used as a screening method to identify infants who need a fuller neurological examination.

In summary, the Brief-HINE is a valuable tool for assessing the neurological health of infants, aiming to improve early detection and management of potential issues during a critical developmental period.